High Times
Home > Boards > US OTC > Internet - Information/Portals >

MariMed Inc. (MRMD)

MRMD RSS Feed
Add MRMD Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/19/2018 11:49:29 PM - Followers: 79 - Board type: Free - Posts Today: 0

Welcome
Link to Marimed website:
https://marimedadvisors.com/
Link to Marimed Facebook page:
https://www.facebook.com/marimedinc/

Marimed brands:

TIKUN OLAM USA:
https://tikunolamusa.com/strainpage/
Home / Alaska™
Alaska_Page

Alaska™

5 out of 5 based on 3 customer ratings
(3 customer reviews)

 

INVIGORATING, ELEVATING, STIMULATING

  • Indica: 30%
    Sativa: 70%
    THC Range: 20-23%
    CBD Range: >1%
    Used For: Depression, anxiety, nausea, stimulating appetite, and gastrointestinal ailments.
    Day Care / Night Care: Day Care
    Available In: Flower, Vape, Topical, Tincture

Product Description

Alaska, is a stimulating and energizing THC sativa strain that is great for daytime use. It is helpful for alleviating anxiety and depression, combating nausea, diminishing severe pain, providing relief from the symptoms of gastrointestinal diseases like Crohn’s or Colitis. Increases appetite, increases energy, elevates moood.


Home / Avidekel™
Avidekel_Page

Avidekel™

5 out of 5 based on 4 customer ratings
(4 customer reviews)

 

ENERGIZING, HARMONIZING, STABILIZING

  • Indica: 80%
    Sativa: 20%
    THC Range: >1%
    CBD Range: 16-19%
    Used For: Seizures, migraines, anxiety, inflammation, pain, fibromyalgia and autoimmune disease symptoms.
    Day Care / Night Care: Anytime of Day or Night
    Available In: Flower, Vape, Tincture, Topical

Product Description

Avidekel is a high CBD indica dominant strain with virtually no THC.  It  is non psychoactive and great to consume anytime of day or night. It reduces swelling and relieves inflammatory pain, seizures, and symptoms of autoimmune diseases like MS and ALS.  It can also help diminish migraines, convulsions, and symptoms of epilepsy.

CANADIAN CANNABIS AWARDS #1 TOP HIGH CBD FLOWER AND #1 TOP HIGH CBD OIL


Home / Eran Almog™
Eran_New2

Eran Almog™

 

SOOTHING, COMFORTING, RESTFUL

  • Indica: 70%
    Sativa: 30%
    THC Range: 18-23%
    CBD Range: >1%
    Used For: Chronic or acute pain, insomnia or sedation, muscle spasms, diminishing nausea and increasing appetite.
    Day Care / Night Care: Night Care
    Available In: Flower, Vape

Product Description

Eran Almog is a THC indica dominant hybrid strain great for evening and nighttime consumption.  It is helpful for chronic pain; sleep disorders, nausea, lack of appetite and symptoms of PTSD. As a hybrid, Eran Almog is known for providing significant physical pain relief throughout the body while creating calmness and clarity in the mind.  This strain is ideal for people used to opiates and narcotics or who already have experience medicating with high-THC products.

CANADIAN CANNABIS AWARDS #1 TOP HIGH THC FLOWER


Home / Erez™
Erez_New2

Erez™

 

SERENE, CALMING, SEDATING

  • Indica: 70%
    Sativa: 30%
    THC Range: 15-18%
    CBD Range: >1%
    Used For: PTSD, pain, neurological conditions, sleep and spasticity.

    Day Care / Night Care: Night Care
    Available In: Flower, Vape

Product Description

Erez is a THC indica, named after the first ever Tikun Olam patient.  Best for nighttime use, its strong effects help with sleep disorders, severe pain, and the symptoms of neurological issues like tremors, muscle spasms, PTSD, and Parkinson’s. Erez also relieves intestinal inflammation, helps reduce nausea and improves appetite. It’s recommended for experienced consumers who are accustomed to a higher THC strain.



Home / Midnight™
Midnight_Page

Midnight™

5 out of 5 based on 2 customer ratings
(2 customer reviews)

 

BALANCING, CALMING, EQUALIZING

  • Indica: 30%
    Sativa: 70%
    THC Range: 8-12%
    CBD Range: 9-14%
    Used For: Anxiety, depression, fibromyalgia, PTSD, muscle or joint pain and inflammation and neurological ailments.
    Day Care / Night Care: Anytime of Day or Night
    Available In: Flower, Vape, Tincture, Topical

Product Description

Midnight, a 1:1 CBD to THC sativa strain that is ideal for use anytime of day or night and has a grounding and relaxing effect. Midnight relieves the symptoms of fibromyalgia, tinnitus, Parkinson’s, gastrointestinal ailments and PTSD. It is calming to the mind and body and provides effective relief from mild pain and tremors.  Great for new cannabis patients who wish to start with a lower THC strain as well as seasoned consumers who need a balanced strain for anytime day.

CANADIAN CANNABIS AWARDS #2 TOP HYBRID



Home / Or™
Or_New2

Or™

 

RELAXING, TRANQUIL, CAREFREE

  • Indica: 70%
    Sativa: 30%
    THC Range: 14-17%
    CBD Range: 1%
    Used For: Sleep disorders, pain, muscle spasms, appetite stimulant, and respiratory conditions.
    Day Care / Night Care: Night Care
    Available In: Flower, Vape

Product Description

Or is a THC indica strain that provides deep relaxation and soothing comforting nighttime relief.  It helps relieve nausea, severe pain, loss of appetite, spasticity, respiratory issues, and insomnia.


BETTY EDDIES:
Image result for betty eddiesImage result for betty eddies     Image result for betty eddies Image result for betty eddies
                            Image result for betty eddies Image result for betty eddies EDIBLES
http://www.bettyseddies.com/

KALM FUSION:
Image result for KALM FUSION Image result for KALM FUSION Image result for KALM FUSION Image result for KALM FUSION
https://kalmfusion.com/

LUCID MOOD:
 Image result for LUCID MOOD Image result for LUCID MOOD Image result for LUCID MOOD
https://www.lucidmood.net/

NATURE'S HERITAGE:

Image result for NATURE'S HERITAGE  Image result for NATURE'S HERITAGE  Image result for NATURE'S HERITAGE Image result for NATURE'S HERITAGE Image result for NATURE'S HERITAGE Image result for NATURE'S HERITAGE Image result for NATURE'S HERITAGE Image result for NATURE'S HERITAGE


Image result for NATURE'S HERITAGE Image result for NATURE'S HERITAGE Image result for NATURE'S HERITAGE Image result for NATURE'S HERITAGE Image result for NATURE'S HERITAGE
https://kindtherapeuticsusa.com/natures-heritage/

IROLLIE:
Image result for irollie Image result for irollie  Image result for irollie PRODUCTS Related image Image result for SMOKUS LED
https://irollie.co/


Link to year end shareholder letter for fiscal year 2017 (January 18, 2018):
https://globenewswire.com/news-release/2018/01/18/1296313/0/en/MariMed-CEO-Issues-2017-Year-End-Letter-to-Shareholders.html




Events since the shareholder letter:

MariMed Introduces Licensed Nature’s Heritage Cannabis® Brand in Maryland (April 2018)

https://globenewswire.com/news-release/2018/04/24/1486187/0/en/MariMed-Introduces-Licensed-Nature-s-Heritage-Cannabis-Brand-in-Maryland.html

Nature’s Heritage Cannabis is Rooted in Excellence: “The best cannabis Mother Earth has to offer”

MariMed's Nature's Heritage Cannabis (tm) products: Rooted in Excellence
Nature's Heritage products

MariMed’s new Nature’s Heritage Cannabis™ branded products are “rooted in excellence” -- produced from the finest marijuana seed lineages from across the globe. Produced and distributed by Kind Therapeutics USA they are now available in dispensaries throughout Maryland.

NEWTON, Mass. and HAGERSTOWN, Md., April 24, 2018 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQB:MRMD) and Kind Therapeutics USA today debuted Nature’s Heritage Cannabis®, a branded line of organic marijuana products that is “Rooted in Excellence.”  MariMed has sought out the finest seed lineages in the world and developed them into “The best cannabis Mother Earth has to offer®.”  MariMed selected only the best strains that perfectly embody the rich heritage and subtle nuances of their origins. Nature’s Heritage Cannabis products are produced from genetically pure strains, now 100% organically grown at the Kind Therapeutics USA’s state licensed cultivation facility in Hagerstown, Maryland. This facility is managed by MariMed Inc.

Nature’s Heritage Cannabis branded products include:

  • Flower – bulk and prepackaged.  Each natural bud is coated in crystal-like resin rich with THC and CBD.
    Concentrates – CO2 wax, live resin, shatter, CO2 terp sauce and budder skillfully made from choice strains, capturing the smell, taste and effects of the original plant.
    Vape Pens – cartridges and mini pens, and disposable pens contain premium oil that has been extracted from the world’s finest cannabis plants, preserving the aroma, flavor and effect of the original plant.
    Extracts – tinctures, capsules, topicals and RSO syringes.  Famous for its cancer wonders, pure RSO oil is 100% pure premium cannabis oil with all the cannabinoids that offer the same beneficial effects as the original plant in easy to use products.

“Nature’s Heritage Cannabis is all about experiencing the rich heritage and medicinal benefits of the finest lines of cannabis from every corner of the world,” stated Tim Shaw, MariMed COO who heads up Product Development.  “’Each product is stamped with ‘Rooted in Excellence,’ which exemplifies how we have gone back to the basics of organic farming with these heirloom lines and carefully manage every step of the process from seed to sale.  This ensures that patients can enjoy marijuana’s full potential at its very best, purest state - free of pesticides and contaminants - as it was centuries ago, yet in convenient products that fit today’s lifestyles and meet their medical needs.”

“The Nature’s Heritage Cannabis brand has an adventurous ‘Old World’ treasure hunt look with antiqued parchment packaging and maps showing the origin and history of each of the treasured cannabis strains,” noted Tim Tennant, MariMed Chief Marketing Officer.  “We really want patients to explore the effectiveness of the Nature’s Heritage strains in treating their symptoms and develop a true appreciation for how their power has been harnessed in convenient, ready to use products.”

Kind Therapeutics USA grows Nature’s Heritage Cannabis Sativa, Indica and Hybrid strains in its cultivation facility in Hagerstown, Maryland.  Its adjoining production facility manufactures products in THC and CBD formulations and distributes them to dispensaries throughout Maryland. MariMed Inc. developed and provides management oversight of this facility including its product selection and all its operations.    For more information on Nature’s Heritage at Kind, visit https://kindtherapeuticsusa.com/natures-heritage/


MariMed Signs LOI to Invest in Cannabis Venture Partners to Expand Sprout CRM Platform Throughout Cannabis Industry (June 2018)
https://globenewswire.com/news-release/2018/06/29/1531696/0/en/MariMed-Signs-LOI-to-Invest-in-Cannabis-Venture-Partners-to-Expand-Sprout-CRM-Platform-Throughout-Cannabis-Industry.html

CVP focused on utilizing technology, data and content to accelerate growth and connect cannabis brands to consumers

NEWTON, MA, June 29, 2018 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQB: MRMD), a seed to sale cannabis company, and Cannabis Venture Partners, LLC (CVP), developers of Sprout, an innovative CRM and marketing software platform for the cannabis industry, today announced that MariMed has signed a letter of intent (LOI) to make a strategic investment in Cannabis Venture Partners.  

"MariMed and Cannabis Venture Partners share the same vision and ambition to deliver incredible experiences to millions of cannabis consumers and businesses all around the globe,” said MariMed CEO, Robert Fireman.  “We are excited about the growth potential of this investment and partnership opportunity with CVP as they transform the way cannabis businesses engage and market to the consumer.”

CVP’s flagship technology, Sprout, is an all-in-one CRM and marketing software designed for dispensaries and cannabis brands.  The Sprout software platform is used today by dispensaries and cannabis brands in nine states and its clients - brands and dispensaries - typically achieve 10x return on their marketing spend to acquire, retain, and increase share of wallet with their customers.

“We have been big fans of Sprout’s marketing engine and it has helped MariMed acquire new customers and keep them coming back,” stated Jon Levine, CFO of MariMed.  “We’ve been using their technology for several years now and it is undeniably the best CRM and marketing platform in the cannabis industry today.”

Through its partnership with MariMed, Cannabis Venture Partners will continue to develop and expand the Sprout platform and launch new technologies, data and content that are consumer-centric and help dispensaries and cannabis brands increase sales, improve customer loyalty and reach more customers.

"We are excited to partner with MariMed, a forward-thinking innovator with a stellar record of success in the cannabis industry,” stated Jaret Christopher, CEO of Cannabis Venture Partners.  “With MariMed’s industry expertise and international reach, our partnership will help us realize our shared goal of utilizing technology, data and content to deliver cannabis around the world.”.

About Cannabis Venture Partners, LLC.

Cannabis Venture Partners, LLC owns and operates proprietary technology, data and content related businesses that connect cannabis companies with consumers.  The Company’s flagship product, Sprout, is an all-in-one CRM and marketing software used by dispensaries and cannabis brands.
For additional information visit: www.cannabisventurepartners.com or www.sprout.online


Navy Capital Invests $2.0 Million in MariMed (July 2018)

https://globenewswire.com/news-release/2018/07/19/1539540/0/en/Navy-Capital-Invests-2-0-Million-in-MariMed.html

Investment helps fund the continued growth of MariMed assets

NEWTON, MA and NEW YORK, July 19, 2018 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQB: MRMD), a multi- state professional cannabis organization which develops, owns and manages cannabis facilities and branded products lines, announced today that Navy Capital Green Fund, LP (Navy Capital), has made a $2.0 million investment in MariMed. The Navy Capital Green Fund is the first US-based Long/Short Public Equity Fund dedicated to identifying attractive best in class businesses within key verticals of the global legal cannabis industry. The investment will help fund the continued growth of MariMed assets, including the build-out of cannabis facilities in Massachusetts that are scheduled to open by yearend 2018.

“MariMed is one of the top multi-state cannabis operators in the US. We are delighted to be making this first investment to support their continued growth in Maryland, three sites in Massachusetts, and their plans for projects in additional states,” said Sean Stiefel, Navy Capital portfolio manager. “We are looking to synergistically align MariMed’s branded cannabis-infused product lines with other investments we’ve made in the industry.  MariMed aligns closely with our investment philosophy of supporting businesses with strong revenue streams, compelling strategic growth plans, and management teams that are deeply invested in the business and committed to the industry and their customers.”

“This placement by one of the top investment houses in cannabis demonstrates Navy Capital’s confidence in our strategic plan and our potential for asset and revenue growth,” stated Robert Fireman, MariMed CEO. “We’ve had 11 consecutive quarters of year over year revenue growth, and Navy Capital’s infusion will help further facility development and expand corporate infrastructure, in turn bolstering assets, increasing revenue, and delivering financial performance.”

About Navy Capital

Navy Capital’s research-oriented, fundamentally driven investment process focuses on identifying attractive opportunities within the legal cannabis space. Navy Capital seeks to find the best in class businesses within key verticals of the global cannabis industry. Those verticals include Consumer, Healthcare, Technology, Industrials, and Agriculture. 
?
What We Look For

Navy Capital invests in 20-30 publicly traded and select private companies that will gain market share over time in their respective verticals. Businesses that have recurring revenue and management teams that have a large share of their net worth in the company and are deeply passionate about their culture and customers are the most attractive to us. 

For more information, visit navycapital.com

 

MariMed Acquires iRollie to Support MariMed Brands, Expand into Ancillary Cannabis Service Offerings (July 2018)

https://globenewswire.com/news-release/2018/07/24/1541215/0/en/MariMed-Acquires-iRollie-to-Support-MariMed-Brands-Expand-into-Ancillary-Cannabis-Service-Offerings.html

Acquisition includes:

      ? Brand, web, packaging development services and solutions,

      ? iRollie intellectual property

      ? Smoking accessories and e-commerce marketplace

NEWTON, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- MariMed Inc., (OTCQB:MRMD) today announced it has acquired iRollie LLC, including its intellectual property (IP), clients, and its host of products and services. MariMed hired iRollie’s cofounders Luke Shepter and Joe Khoury to expand the iRollie business as well as to bring their expertise and services in house to support MariMed brands and clients. MariMed acquired iRollie and its executives in exchange for $600,000 in MariMed stock.  

The acquisition enables MariMed to round out its ownership portfolio with an ancillary business capable of servicing all existing brands and drive new business, partnerships, and revenue. The MariMed team and iRollie co-founders will be available for interviews at the CannaCon Boston Conference, July 27-28 at MariMed Booth #128, Hynes Convention Ctr. 

“MariMed identified a number of synergies between our two companies that we felt best to bring in-house to strengthen internal capabilities. We continue to set new standards in the industry with innovative all-natural cannabis products requiring premium branding, packaging, and marketing as well as strategic sourcing,” stated Tim Shaw, MariMed COO. “iRollie enables an in-house ability to develop, improve and effectively market new and existing brands, as well as add a fast-growing revenue stream of proprietary product offerings to MariMed’s financials.”

The iRollie team designed, prototyped, and produced custom products and packaging for cannabis companies in Massachusetts, Nevada, Colorado, Maine, with distribution facilities in Nevada and Pennsylvania. The co-founders bring formidable talent to MariMed with Khoury’s strong background in cannabis early strategic growth, digital marketing, supply chain management and Shepter’s expertise in redeveloping processing operations for recreational marijuana-infused products, with a strong focus on reducing production costs and increasing scalability. 

“We are excited to apply our experience scaling cannabis brands in both recreational and medical markets to create best in class brands,” stated Shepter. “We believe these brands will capture the hearts and minds of B2B customers and consumers alike, and that our synthesis of cutting edge design of physical assets and digital technology will enhance customer retention and maximize ROI,” Khoury concluded.



MariMed Secures Exclusive Global Licensing, Distribution for Vitiprints Revolutionary, Proprietary Cannabis Printing Technology (August 2018)
https://globenewswire.com/news-release/2018/08/02/1546266/0/en/MariMed-Secures-Exclusive-Global-Licensing-Distribution-for-Vitiprints-Revolutionary-Proprietary-Cannabis-Printing-Technology.html

? Platform creates new category of precision dosed dissolvable cannabis products at efficiencies unsurpassed in the industry.

? Cannabis-infused medium enables rapid delivery sublingually, transdermally, or in liquid.

? The Vitiprints platform efficiently layers ingredients and graphic design, offering endless options for amazing customer products, experiences.

NEWTON, Mass., NEW YORK, Aug. 02, 2018 (GLOBE NEWSWIRE) -- MariMed Inc., (OTCQB:MRMD) today announced that it has signed an exclusive global licensing agreement with Vitiprints™ for the worldwide production and distribution rights in all existing and future legal cannabis markets. The agreement extends to all cannabis products made using Vitiprints’ proprietary technology, including liquid ingredient formulation, printing process, and the resulting array of dissolvable products.

“Our exclusive agreement with Vitiprints puts MariMed on the forefront of precision-dosed branded cannabis products and technology that will, above all, delight consumers with a revolutionary product category and experience,” said Robert Fireman, MariMed CEO. “This innovative technology enables creation of infused cannabis products which can be specifically designed for dosage, flavor, and supplements to achieve the desired effect or result. These products can be manufactured at speeds and efficiencies that will create cost savings for producers and consumers, while generating significant incremental revenue streams for MariMed from sales and sublicensing agreements.”

The patent-pending Vitiprints technology – a first for the cannabis industry -- is already under development for consumer consumption in other industries. For MariMed, the platform combines multiple layers of marijuana ingredients, such as cannabinoids, terpenes, graphic design elements and other ingredients, into a paper-thin low-calorie product that is delivered sublingually, transdermally, or by drinking when dissolved in any liquid.  The product can be used to create its own beverage or tea or as an enhancement to other beverages. Achieving total control over the ingredient layers, the platform further enables precision dosing and fast absorption, without the additional fillers commonly found in cannabis and nutraceutical products. This product transports easily in purses, pockets, and wallets with seamless discretion and convenience.

“MariMed’s management immediately recognized the advantages Vitiprints offered for flexibility in production, dosage, and design and how this is a game changing array of products for the cannabis industry,” stated Andrew Ferber, Co-founder and CEO. “We chose to partner with MariMed from the myriad of cannabis companies because their strategic vision and goals are aligned with ours and we have confidence their extensive experience as multi-state operators with a growing national distribution network will help us quickly penetrate the U.S. and international cannabis markets. We will continue to work with MariMed to develop new innovative products for this emerging industry.”

MariMed expects to complete test marketing of the dissolvable product sets in a MariMed-managed facility within 90 days, then launch in legal states across the country, and finally expand worldwide via sublicense agreements with qualified manufacturers and distributors. Products will be available on shelves as early as the end of Q4 2018.

“Vitiprints is ideally suited and ‘future proof’ against the widely differing and ever-changing cannabis regulations regarding dosing, formulation and appearance, enabling instant modification via the user interface versus a complete product redesign,” said Ryan Crandall, MariMed VP of Brand and Licensing. “Furthermore, we are able to engage customers by using printed design layers as a touch point into our customer education and engagement portal, in turn generating loyalty and feedback. It’s a dream come true for product development and marketing teams,” Crandall added.



Video clip of projected future revenue being presented at LD Micro convention (May 2018):
https://www.facebook.com/marimedinc/videos/389512388200069/?t=3
NOTE: THERE ARE TWO REVENUE PROJECTIONS FOR FISCAL YEAR 2019.THE RANGE IS $68 MILLION ON THE LOW END, AS WELL $108 MILLION ON THE HIGH END. EACH MARKET IS AT DIFFERENT STAGES OF LEGALIZATION, HENCE THE RANGE.

Largest U.S. MJ Companies August 2018

Company Name
Kush Bottles CV Sciences Green Thumb Industries Tilray Terra Tech MedMen Enterprises GrowGeneration GW Pharma Innovative Industrial Properties Golden Leaf Holdings Marimed
Stock Symbol OTCQB: KSHB OTCQB: CVSI OTCQX: GTBIF NASDAQ: TLRY OTCQX: TRTC CSE: MMEN OTCQB: GRWG NASDAQ: GWPH NYSE: IIPR OTCBB: GLHD OTC: MRMD
Headquarters Santa Ana, California Las Vegas, Nevada Chicago, Illinois Nanaimo, British Columbia, Canada Irvine, California Culver City, California Denver, Colorado Cambridge, United Kingdom San Diego, California Toronto, Ontario, Canada Newton, Massachusetts
Quarter Ended 5/31/2018 6/30/2018 3/31/2018 3/31/2018 6/30/2018 3/31/2018 6/30/2018 6/30/2018 6/30/2018 3/31/2018 6/30/2018
Quarterly Sales $12.9 Million $12.3 Million $10.9 Million $7.8 Million $7.2 Million $7.2 Million $7.2 Million $3.5 Million $3.3 Million $3.2 Million $2.9 Million
Current Assets $26.66 Million $14.26 Million N/A N/A $18.35 Million N/A $27.01 Million N/A   $28.41 Million $12.26 Million
Total Assets $84.54 Million $27.03 Million N/A N/A $109.79 Million N/A $32.05 Million N/A $161,699.00 $92.56 Million $45.44 Million
Current Liabilites $10.90 Million $3.01 Million N/A N/A $5.97 Million N/A $2.61 Million N/A   $3.98 Million $16.09 Million
Long Term Liabilities $1.34 Million $2.26 Million N/A N/A $12.81 Million N/A $4.80 Million N/A Total liabilities is $10,114.00 Total liabilities is $39.28 Million Mortgage principle of $7.47 Million
Total Equities $72.31 Million $21.75 Million N/A N/A $91.01 Million N/A $24.64 Million N/A $151,585.00   $21.64 Million
Y/Y Growth 173% 203% 262% 55% 19% 693% 74% 9% 157% 42% 81%
Next Financials 11/29/2018 11/14/2018 8/29/2018 8/9/2018 11/9/2018 9/28/2018 11/14/2018 12/9/2018 11/9/2018 8/29/2018 11/14/2018

NOTE: COMPANIES WITH N/A IN CATEGORIES DO NOT HAVE ANNUAL/QUARTERLY REPORTS AVAILABLE TO THE PUBLIC.

MARIMED (MRMD) IS THE FIRST PUBICLY TRADED MJ COMPANY ON THE EAST COAST TO EARN MORE THAN $2.5 MILLION DOLLARS PER QUARTER. (AS OF AUGUST 19, 2018)

Link  to public cannabis venture tracker of the largest pubicly traded mj companies in Canada & the U.S.

https://www.newcannabisventures.com/cannabis-company-revenue-ranking/
High Times
MRMD
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#881   Nice, most of the Cannabis market down MRMD Etailer 10/19/18 11:49:29 PM
#880   sweet Rocketstockpix 10/19/18 12:26:11 PM
#879   Good call Johnny. Nice and green today. $MRMD midtownmurphy 10/19/18 12:25:48 PM
#878   time to buy it up then Rocketstockpix 10/19/18 12:25:22 PM
#877   I think they were just using the Canada SmokeABull 10/18/18 10:36:49 AM
#876   4.20 buy buy buy. I do not have JohnCM 10/17/18 04:02:19 PM
#875   Pretty dispiriting to watch it go from a Pied4piper4 10/17/18 04:00:37 PM
#874   Catching up for newbies. August 15th, 2018. JohnCM 10/17/18 03:28:46 PM
#873   Not terrible ... JohnCM 10/17/18 03:23:39 PM
#872   $4.40 golden opportunity. JohnCM 10/17/18 03:20:48 PM
#871   https://www.nasdaq.com/press-release/marimed-to-be-featured-at-canaccord-genuity TraderJoe03 10/17/18 12:47:27 PM
#870   Someone is liquidating today :-( midtownmurphy 10/17/18 10:53:22 AM
#869   At least there hasn’t been any major dumping. SmokeABull 10/17/18 09:48:58 AM
#868   Yup! SmokeABull 10/17/18 09:37:02 AM
#867   Anxiously waiting to see if the Canada news midtownmurphy 10/17/18 09:21:13 AM
#866   Yeah that’s right...goes to show they know what SmokeABull 10/16/18 08:46:22 PM
#865   I meant the 1.5 million volume for Monday, Pied4piper4 10/16/18 07:31:07 PM
#864   How could there have been a 1.5 million 420Hope 10/16/18 04:02:27 PM
#863   Was the word here MaxPow 10/16/18 02:41:40 PM
#862   Do I have to create a second username Pied4piper4 10/16/18 01:11:43 PM
#861   Ok, I’ll go two in a row. Looked Pied4piper4 10/16/18 12:04:08 AM
#860   If that 3.68 arrangement can be seen to Pied4piper4 10/13/18 12:28:53 PM
#859   Nice post Shawn Trade. I bought into this SC1717 10/12/18 06:58:53 PM
#858   Good points. I loaded up 27% ago. Why? ShawnTrade 10/12/18 06:42:20 PM
#857   Nice recovery the last few hours yesterday and SC1717 10/12/18 06:06:26 PM
#856   Boy, all morning, I’ve been prevented from posting. Pied4piper4 10/12/18 01:00:42 PM
#855   It's getting some great support today!! $MRMD midtownmurphy 10/12/18 11:37:10 AM
#854   But, I do note that most of us Piedpiper4 10/11/18 09:32:30 PM
#853   I think the call that 3.68 is a Piedpiper4 10/11/18 06:23:52 PM
#852   The move up in the last 10 minutes 420Hope 10/11/18 04:05:54 PM
#851   This stock is to Rocky as the shorts SmokeABull 10/11/18 03:31:38 PM
#850   Tried at 3.71 but no. Think it might Piedpiper4 10/11/18 03:08:43 PM
#849   I’d missed your post 420. I agree it Piedpiper4 10/11/18 01:58:30 PM
#848   The Irish are tragic poets, not pragmatists! The Piedpiper4 10/11/18 01:57:02 PM
#847   I picked up more down here 420Hope 10/11/18 01:54:43 PM
#846   Let’s hope it’s always darkest before dawn SmokeABull 10/11/18 12:38:15 PM
#845   I don't know that Irish woman, but she clonk 10/11/18 12:27:32 PM
#844   Well, we’ve breached the 3.68 point and I Piedpiper4 10/11/18 12:24:58 PM
#843   It is being shorted to death. It will clonk 10/11/18 11:58:26 AM
#842   IMO, It was a planned assault by some SmokeABull 10/11/18 11:44:38 AM
#841   Why is this dropping so much? Randyfloyd420 10/11/18 11:12:41 AM
#840   I think the magic number is 3.68 as SmokeABull 10/11/18 10:26:41 AM
#839   So the high of the previous run about Bescaredxx 10/11/18 10:11:21 AM
#838   Ugh I really like what this company is TraderJoe03 10/11/18 09:56:23 AM
#837   I always had my eye on PalliaTech in SmokeABull 10/11/18 09:24:01 AM
#836   I put some of my profits from mrmd MRE1980 10/11/18 09:12:23 AM
#835   And I actually meant to suggest that although Piedpiper4 10/10/18 11:39:24 PM
#834   Yeah, I'm stuck in the same boat. All MRE1980 10/10/18 07:48:56 PM
#833   On June 14, it hit an intraday high Piedpiper4 10/10/18 06:39:43 PM
#832   ut oh, Not good.... DD 10/10/18 04:13:44 PM
PostSubject